Tiara™ Transcatheter Mitral Valve Replacement Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 157 participants.

Also called NCT03039855

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 157 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03039855
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, Israel, Italy, Netherlands, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03039855. Allocation not applicable; no masking; primary purpose treatment. Start 2017-03-08 (actual); primary completion 2019-12-19 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tiara™ Transcatheter Mitral Valve Replacement Study
Acronym
TIARA-II
Condition
Mitral Valve Regurgitation
Intervention (Device)
TIARA valve and transapical delivery system
Lead sponsor
Shockwave Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03039855
Content hash
6116881be8dc1603be30e3dcceac95786ca2a454b4547aef244579736fbc9e2d